Standout Papers
Citation Impact
3 by Nobel laureates 24 from Science/Nature 73 standout
Citing Papers
Y chromosome loss in cancer drives growth by evasion of adaptive immunity
2023 StandoutNature
LAG-3 as the third checkpoint inhibitor
2023 Standout
Works of Joel Jiang being referenced
Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial
2018 Standout
Sequential administration of nivolumab and ipilimumab with a planned switch in patients with advanced melanoma (CheckMate 064): an open-label, randomised, phase 2 trial
2016
Author Peers
| Author | Oncology | Molecular Biology | PRM | Immunology | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|
| Joel Jiang | 2379 | 944 | 640 | 908 | 23 | 3.5k | |
| Sasun Yakubov | 25 | 321 | |||||
| M. Dulick | 32 | 1.0k | |||||
| Gillian Wheater | 79 | 115 | 5 | 26 | 7 | 345 | |
| Kannayakanahalli M. Dayananda | 9 | 84 | 40 | 80 | 12 | 313 | |
| Manuel E. Ruiz-Sandoval | 1 | 9 | 550 |
All Works
Loading papers...